Q: Any news for the welcomed increase of 0.29 to $5.65? Can it be sustained? Is it time to get back in Txs for u usual great services & advices
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
BMO Equal Weight US Health Care Hedged to CAD Index ETF (ZUH $65.48)
-
Harvest Healthcare Leaders Income ETF (HHL $7.37)
Q: What Canadian ETF would you recommend for exposure to Biotech?
Q: What Canadian biotech companies would you recommend?
Q: Hello,
With their clinical trial in progress what are your thoughts on SONA's potential as well as current price as far as entry point. Also given the level of vaccinations performed do you think that there still will be a high demand for screening alternatives by the addressable market? Thank you!
With their clinical trial in progress what are your thoughts on SONA's potential as well as current price as far as entry point. Also given the level of vaccinations performed do you think that there still will be a high demand for screening alternatives by the addressable market? Thank you!
Q: What is your opinion of BNTX as a 3 year plus hold. Do you believe there is evidence to show there technology is transferable to cancer and flu vaccines. Do you see any potential downside to purchasing the stock at this time or are there other companies that you would prefer in this sector. Thanks
-
Illumina Inc. (ILMN $101.80)
-
Invitae Corporation (NVTA)
-
CRISPR Therapeutics AG (CRSP $54.32)
-
Twist Bioscience Corporation (TWST $28.59)
Q: What is your long term outlook on the above companies.
I own them and some ARKG. Do you have any others you fell would complement them? I got space to add another name or two with out being overweight in the sector.
I own them and some ARKG. Do you have any others you fell would complement them? I got space to add another name or two with out being overweight in the sector.
Q: What is your opinion on their earnings? They seem pretty good to me. Maybe I’m missing something?
Thanks John
Thanks John
Q: Could I get your current opinion of this stock please.
Q: Hello
Could you comment on MBCN earnings?
Thank you
Could you comment on MBCN earnings?
Thank you
Q: Thoughts on the quarter?
Q: The seemingly good Q1 report failed to revive the sacking share price. Is there any other catalyst waiting in the wing? I'm tire of waiting and dead money should be recognized as dead money and move on.
Q: Is there hope for this company?. Insiders are selling since the end of the lockup period in march. Down 15% today after earnings. Is there something wrong with their business model in telemedecine? Hold, sell or buy ? Thanks for your good work.
Q: Would this be a good time to start a new position in WELL?
Q: Good morning team,
Any idea why GUD has halted?
Thx!
Any idea why GUD has halted?
Thx!
Q: Thoughts on the leadership change? Would you consider this material news that will impact the shares (positively or negatively)?
-
Boston Omaha Corporation Class A (BOMN)
-
Invitae Corporation (NVTA)
-
Twist Bioscience Corporation (TWST $28.59)
-
Lemonade Inc. (LMND $56.82)
Q: As I watch the growth stocks in my portfolio get crushed I can't help but also feel excited at the buying opportunities that are being created for others I thought I had missed. With the Nasdaq only 1200 points off its high and companies like TWST (down 57%), LMND (down to 60%) or BOMN (down 50%) or NVTA (down 55%) it is undeniable that many of these stocks have been revalued.
My question pertains both to these specific companies and smaller caps in general. Do you think companies like these are close to finding a floor meaning that it is time to start buying in tranches as they inch down or do you consider it more likely that we need a major sell off and full capitulation?
With these specific companies, what would be an entry price that makes sense for each for the first 1/2 and then a full position. (ie buy a 1/2 of LMND at 75 and then full at 60 if it gets there).
My question pertains both to these specific companies and smaller caps in general. Do you think companies like these are close to finding a floor meaning that it is time to start buying in tranches as they inch down or do you consider it more likely that we need a major sell off and full capitulation?
With these specific companies, what would be an entry price that makes sense for each for the first 1/2 and then a full position. (ie buy a 1/2 of LMND at 75 and then full at 60 if it gets there).
Q: Hi 5i Team,
Pls comment on Profound Medical earning report and the future going forward. Share price was drifting lower lately and a further 10% drop in US extended hour trading. Is this stock a hold or sell in your view?
Thank you for your professional guidance as always.
Pls comment on Profound Medical earning report and the future going forward. Share price was drifting lower lately and a further 10% drop in US extended hour trading. Is this stock a hold or sell in your view?
Thank you for your professional guidance as always.
Q: AVEO Oncology share price jumped after it got FDA approval for
FOTIVDA® (tivozanib) around 2 months ago. It ramped up for this by securing capital, and issued new equity, @ $ 8.00 which was fully subscribed, including all offered additional shares. New Director appointed who seems to be quite an authority on cancer research.
Unfortunately. the Share price dropped after the spike on approval, and has fallen back to old levels. what seems to be the problem ? When do you think, if at all, the price will reach the lofty levels recommended by the Analysts covering it.
Thanks and Appreciate all the advise and guidance you and your team provides.
Rajesh
FOTIVDA® (tivozanib) around 2 months ago. It ramped up for this by securing capital, and issued new equity, @ $ 8.00 which was fully subscribed, including all offered additional shares. New Director appointed who seems to be quite an authority on cancer research.
Unfortunately. the Share price dropped after the spike on approval, and has fallen back to old levels. what seems to be the problem ? When do you think, if at all, the price will reach the lofty levels recommended by the Analysts covering it.
Thanks and Appreciate all the advise and guidance you and your team provides.
Rajesh
Q: May I please have your comments on the earnings for both companies. Thank you
Q: Could you comment on Pliant Therapeutics Inc recent results? Could you also analyze and comment on your pro's and cons of the company so far concerning balance sheet, industry, pipeline , insider holdings and management. Thanks.